Gene polymorphism of matrix metalloproteinase-12 and -13 and association with colorectal cancer in Swedish patients

Anticancer Research

Volumn 33, Issue 8, 2013, Pages 3247-3250

  Van Nguyen, Song ^a   Skarstedt, Marita ^b   Lofgren, Sture ^b   Zar, Niklas ^b   Andersson, Roland E ^b   Lindh, Mikael ^b   Matussek, Andreas ^b   Dimberg, Jan ^c  

^a Da Nang University of Medical Technology and Pharmacy   (Viet Nam)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c JÖNKÖPING UNIVERSITY   (Sweden)

Author keywords

Colorectal cancer; MMP12; MMP13; SNP

Indexed keywords

COLLAGENASE 3; MACROPHAGE ELASTASE;

ADULT; AGED; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

COLORECTAL CANCER; MMP12; MMP13; SNP;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN;

EID: 84883288893     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kamangar F, Dores GM and Anderson WF: Patterns of cancer incidence, mortality and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150, 2006.
2. Al-Sohaily S, Biankin A, Leong R, Kohonen-Corish M and Warusavitarne J: Molecular pathways in colorectal cancer. J Gastroenterol Hepatol 27: 1423-1431, 2012.
3. Markowitz SD and Bertagnolli MM: Molecular origins of cancer: Molecular basic of colorectal cancer. N Eng J Med 361: 2449-2460, 2009.
4. McLeod HL and Murray GI: Tumor markers of prognosis in colorectal cancer. Br J Cancer 79: 191-203, 1999.
5. Stetler-Stevenson WG: The role of matrix metalloproteinases in tumor invasion, metastasis and angiogenesis. Surg Oncol Clin N Am 10: 383-392, 2001.
6. Sengupta N and MacDonal ME: The role of matrix metalloproteinases in stromal/epithelial interactions in the gut. Physiology 22: 401-409, 2007.
7. Murray GI, Duncan ME, O'Neil P, Melvin WT and Fothergrill JE: Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 2: 461-462, 1996.
8. Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Kahari VM and Pyrhonen S: High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease free survival in human metastatic melanoma. Int J Cancer 97: 432-438, 2002.
9. Hughes S, Agbaje O, Bowen RL, Holliday DL, Shaw JA, Duffy S and Jones JL: Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression. Clin Cancer Res 13: 6673-6680, 2007.
10. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002.
11. Folgueras AR, Pendas AM, Sanchez LM and Lopez-Otin C: Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48: 411-424, 2004.
12. Leeman MF, McKay JA and Murray GI: Matrix metalloproteinases activity is associated with poor prognosis in colorectal cancer. J Clin Pathol 55: 758-762, 2002.
13. Roeb E, Arndt M, Jansen B, Schumpelick V and Matern S: Simultaneous determination of matrix metalloproteinases (MMP)- 7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas. Int J Colorectal Dis 19: 518-524, 2004.
14. Chaudhary AK, Singh M, Bharti AC, Asotra K, Sundaram S and Mehrotra R: Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. J Biomed Sci 17: 1-13, 2010.
15. Asano T, Tada M, Cheng S , Takemoto N, Kuramae T, abe M, Takahashi O, Miyamoto M, Hamada J, Moriuchi T and Kondo S: Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma. J Surg Res 146: 32-42, 2008.
16. Yamada T, Oshima T, Yoshihara K, Tamura S, Kanazawa A, Inagaki D, Yamamoto N, Sato T, Fujii, Numata K, kunisaki C, Shiozawa M, Morinaga S, Akaike M, Rino Y, Tanaka K, Masuda M and Imada T: Overexpression of MMP13 gene in colorectal cancer with liver metastasis. Anticancer Res 30: 2693-2699, 2010.
17. Borghese B, Chiche JD, Vernerey D, Chenot C, Mir O, Bijaoui, Bonaiti-Pellie C and Chapron C: Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression. Hum Reprod 23: 1207-1213, 2008.
18. Zhou Y, Yu C, Miao X, Wang Y, Tan W, Sun T, Zhang X, Xiong P and Lin D: Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility. Carcinogenesis 26: 1117-1121, 2005.
19. Jormsjo S, Ye S, Moritz J, Walter DH, Dimmeler S, Zeiher AM, Henney A, Hamsten A and Eriksson P. Swanberg M, Lidman O, Padyukov L, Eriksson P: Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimension in diabetic patients with manifest coronary artery disease. Circ Res 86: 998-1003, 2000.
20. Yoon S, Kuivaniemi H, Gatalica Z, Olson JM, Buttice G, Ye S, Norris BA, Malcom GT, Strong JP and Tromp G: MMP13 promoter polymorphisms is associated with atherosclerosis in the abdominal aorta of young black males. Matrix Biology 21: 487-498, 2002.
21. Li Y, Jia JH, Kang S, Zhang XJ, Zhao J, Wang N, Zhou RM, Sun DL, Duan YN and Wang DJ: The functional polymorphisms on promoter region of matrix metalloproteinase-12, -13 genes may alter the risk of epithelial ovarian carcinoma in Chinese. Int J Gynecol Cancer 19: 129-133, 2009.
22. Li Y, Sun DL; Duan YN, Zhang XJ, Wang N, Zhou RM, Cheng ZF and Wang SJ: Association of functional polymorphisms in MMP genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China. Mol Biol Rep 37: 197-205, 2010.
23. Ashida R, Tominaga K, Sasaki E, Watanabe T, Fujiwana Y, Oshitani N, Higuchi K, Mitsuyama S, Iwao H and Arakawa T: AP1 and colorectal cancer. Inflammopharmacology 13: 113-125, 2005.